Protons against cancer: New research beamline for innovative radiotherapies
Prof. Dr Judith Reindl and PhD student Aikaterini Rousseti (from left to right) from the University of the Bundeswehr Munich present the experimental station for biological samples which is installed at the new Minibee beamline at HZB. © Kevin Fuchs / HZB
Magnetic quadrupoles focus the proton beam in front of the experiment platform. © Kevin Fuchs / HZB
Together with the University of the Bundeswehr Munich, the HZB has set up a new beamline for preclinical research. It will enable experiments on biological samples on innovative radiation therapies with protons.
The proton accelerator at the Helmholtz-Zentrum Berlin (HZB) has been used for about 25 years to combat certain types of eye tumours. So far, over 4800 people have benefited from proton eye tumour therapy, which is carried out in collaboration with Charité – Universitätsmedizin Berlin.
Now, the proton accelerator at HZB also offers the option of conducting preclinical research: A mini-beamline for preclinical experiments (Minibee) has been set up for this purpose together with the University of the Bundeswehr in Munich. The HZB's Proton Therapy Department has built the beam guidance and control system for the minibeams. The University of the Bundeswehr in Munich, with Prof. Judith Reindl from the Institute of Applied Physics and Measurement Technology and the Section of Biomedical Radiation Physics, installed a platform for image-guided irradiation of biological samples. This will enable joint experiments on radiobiology and innovative radiation therapy in the future.
‘At Minibee, we can use medical research to investigate how changes in parameters and settings of the proton beam affect the treatment,’ says Judith Reindl. Among other things, Minibee is designed to generate ultrashort proton flashes (FLASH therapy) or needle-fine radiation (beamlets). ‘Our aim is to develop new methods that effectively destroy tumours while providing even better protection for healthy tissue,’ says Prof. Dr. Andrea Denker, head of the Department of Proton Therapy at HZB.
- 3D magnetic field experiment at BESSY II takes spintronics a step further(Fe0.63Ni0.3Pd0.07)3P or FNPP is a magnetic material that exhibits complex magnetic structures even at room temperature. This makes the material of interest for spintronics, a field that could enable data processing with significantly lower energy consumption. One potential application is novel magnetic memory devices. However, generating and modifying the desired structures in a controlled manner remains a challenge to date. A new study led by HZB has now taken a step forward in this regard. They demonstrated at the worldwide unique VEKMAG-Station at BESSY II, that a tiny external B-field in the plane of the magnetic patterns is sufficient to change them.
- Hatice Mutlu appointed to the Helmholtz Institute HIPOLE in JenaProf. Dr Hatice Mutlu is the new professor of sustainable polymer chemistry at HIPOLE Jena, the Helmholtz Institute for Polymers in Energy Applications. On 17 August 2026, she visited the HZB campus in Berlin-Adlershof including the BESSY II lightsource and discussed future collaboration with researchers and the board of directors.
- Special prize by Jugend Forscht awarded to former school internShaoxuan Wang has won a special prize in the Jugend Forscht competition for her project ‘Smart Capsules – intelligent microcapsules for glucose-dependent insulin release’. She designed the project as a “special achievement” for her A-levels. To carry out the experimental work, Shaoxuan was able to spend a further two weeks in the laboratory at the HZB Institute for Electrochemical Energy Storage, where she had completed a school internship two years earlier.